But, like all medications, FDA-approved GLP-1s have risks and benefits
The risk of depression, anxiety, and suicidal behavior in patients with obesity on glucagon like peptide-1 receptor agonist therapy
Researchers concluded that those taking tirzepatide were significantly more likely to achieve weight loss, but added that more studies are needed to better understand the full range of benefits and effects both drugs have on patients
What trials do show is that higher doses are linked to stronger side effects, especially digestive ones
If hair loss begins, consult a medical professional for definitive guidance
Beneficial metabolic effects on pre-diabetic symptoms in edited DIO mice Beyond anti-obesity effects, we evaluated the impact of in vivo knock-in of scExe4 on pre-diabetic symptoms, including high blood glucose levels and low insulin sensitivity, in DIO mice, which are hallmark features of diabetes (Fig